Abstract
Studies performed using in vivo and in vitro experimental model systems are critical components of the effort to identify the effect of new drug molecules. Experimental models permit the precise quantification of exposure levels, to eliminate many external variables that may alter drug response. Experimental studies can be designed in a manner to include specific endpoint evaluations that can generate important data concerning possible biological mechanisms of drug action. Thus, it becomes mandatory to access the cause of disease, and the mechanisms behind it, through experimental models which generally involve animals, in vitro studies, primates, and even humans to a certain extent. Interspecies differences and high-dose to low-dose extrapolations remain important challenges to the interpretation and application of experimental data to assessments of human risk. Understanding the basic mechanisms and pathogenesis of inflammation are essential for the development of new treatment approaches and therapeutic agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vogel HG (2008) Drug discovery and evaluation: pharmacological assays, vol-I, 3rd edn. Springer, Berlin/Heidelberg/New York
Rhaleb NE, Carretero OA (1994) The role of B1 and B2 receptors and of nitric oxide in bradykinin-induced relaxation and contraction of isolated rat duodenum. Life Sci 55:1351–1363
Watanabe K, Kinoshita S, Nakagawa H (1989) Very rapid assay of polymorphonuclear leukocyte chemotaxis in vitro. J Pharmacol Methods 22:13–18
Jung T, Schauer U, Heusser C, Neumann C, Rieger C (1993) Detection of intracellular cytokines by flow cytometry. J Immunol Methods 159:197–207
Sander B, Andersson J, Andersson U (1991) Assessment of cytokines by immunofluorescence and the paraformaldehyde saponin procedure. Immunol Rev 119:65–93
Schreuder HA, Rondeau JM, Tardif C, Soffientini A, Sarubbi E, Akeson A, Bowlin TL, Yanofsky S, Barrett RW (1995) Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline. Eur J Biochem 227:838–847
Yuan JS, Shaham S, Ledoux S, Ellis HM, Horvitz HR (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin 1β-converting enzyme. Cell 75:641
Dinarello CA (1996) Biological basis for interleukin-1 in disease. Blood 87:2095–2147
Tatsuda T, Cheng J, Mountz JD (1996) Intracellular IL-1β is an inhibitor of Fas-mediated apoptosis. J Immunol 157:3949–3957
Parmar NS, Prakash S (2011) Screening methods in pharmacology. Narosa Publishing House, New Delhi, p 211
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer India
About this chapter
Cite this chapter
Jain, P., Pandey, R., Shukla, S.S. (2015). Experimental Models for Inflammation. In: Inflammation: Natural Resources and Its Applications. SpringerBriefs in Immunology. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2163-0_5
Download citation
DOI: https://doi.org/10.1007/978-81-322-2163-0_5
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2162-3
Online ISBN: 978-81-322-2163-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)